nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—ALB—breast cancer	0.498	1	CbGaD
Sodium lauryl sulfate—ALB—Irinotecan—breast cancer	0.0584	0.402	CbGbCtD
Sodium lauryl sulfate—ALB—Fluorouracil—breast cancer	0.056	0.386	CbGbCtD
Sodium lauryl sulfate—ALB—Methotrexate—breast cancer	0.0309	0.213	CbGbCtD
Sodium lauryl sulfate—Decamethonium—ACHE—breast cancer	0.00216	0.63	CrCbGaD
Sodium lauryl sulfate—Decamethonium—BCHE—breast cancer	0.00127	0.37	CrCbGaD
Sodium lauryl sulfate—Hypokalaemia—Doxorubicin—breast cancer	0.000146	0.00046	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Paclitaxel—breast cancer	0.000145	0.000458	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Mitoxantrone—breast cancer	0.000145	0.000457	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Thiotepa—breast cancer	0.000144	0.000456	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Irinotecan—breast cancer	0.000144	0.000455	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Irinotecan—breast cancer	0.000144	0.000455	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Mitoxantrone—breast cancer	0.000144	0.000455	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Mitoxantrone—breast cancer	0.000144	0.000455	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Epirubicin—breast cancer	0.000144	0.000454	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Paclitaxel—breast cancer	0.000144	0.000454	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Paclitaxel—breast cancer	0.000142	0.000447	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Capecitabine—breast cancer	0.000141	0.000445	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Vinorelbine—breast cancer	0.00014	0.000444	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Gemcitabine—breast cancer	0.00014	0.000443	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Methotrexate—breast cancer	0.00014	0.000442	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Thiotepa—breast cancer	0.00014	0.000441	CcSEcCtD
Sodium lauryl sulfate—Rash—Vinorelbine—breast cancer	0.000139	0.00044	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Vinorelbine—breast cancer	0.000139	0.00044	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Doxorubicin—breast cancer	0.000139	0.00044	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Paclitaxel—breast cancer	0.000139	0.000439	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Fluorouracil—breast cancer	0.000139	0.000438	CcSEcCtD
Sodium lauryl sulfate—Headache—Vinorelbine—breast cancer	0.000138	0.000437	CcSEcCtD
Sodium lauryl sulfate—Syncope—Docetaxel—breast cancer	0.000138	0.000437	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Doxorubicin—breast cancer	0.000138	0.000437	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Fluorouracil—breast cancer	0.000138	0.000436	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Docetaxel—breast cancer	0.000136	0.000431	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Docetaxel—breast cancer	0.000136	0.000428	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Irinotecan—breast cancer	0.000134	0.000424	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Mitoxantrone—breast cancer	0.000134	0.000424	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Thiotepa—breast cancer	0.000134	0.000424	CcSEcCtD
Sodium lauryl sulfate—Syncope—Capecitabine—breast cancer	0.000134	0.000423	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Docetaxel—breast cancer	0.000134	0.000422	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Paclitaxel—breast cancer	0.000133	0.000421	CcSEcCtD
Sodium lauryl sulfate—Rash—Thiotepa—breast cancer	0.000133	0.00042	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Doxorubicin—breast cancer	0.000133	0.00042	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Thiotepa—breast cancer	0.000133	0.00042	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Paclitaxel—breast cancer	0.000133	0.000418	CcSEcCtD
Sodium lauryl sulfate—Headache—Thiotepa—breast cancer	0.000132	0.000417	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Capecitabine—breast cancer	0.000132	0.000417	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Docetaxel—breast cancer	0.000131	0.000415	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Capecitabine—breast cancer	0.000131	0.000415	CcSEcCtD
Sodium lauryl sulfate—Nausea—Vinorelbine—breast cancer	0.000131	0.000414	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Epirubicin—breast cancer	0.000131	0.000414	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Irinotecan—breast cancer	0.000131	0.000413	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Mitoxantrone—breast cancer	0.000131	0.000413	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Paclitaxel—breast cancer	0.000129	0.000408	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Fluorouracil—breast cancer	0.000129	0.000406	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Paclitaxel—breast cancer	0.000128	0.000405	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Gemcitabine—breast cancer	0.000127	0.000402	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Capecitabine—breast cancer	0.000127	0.000402	CcSEcCtD
Sodium lauryl sulfate—Constipation—Paclitaxel—breast cancer	0.000127	0.000401	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Capecitabine—breast cancer	0.000127	0.0004	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Docetaxel—breast cancer	0.000126	0.000398	CcSEcCtD
Sodium lauryl sulfate—Oedema—Docetaxel—breast cancer	0.000126	0.000398	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Gemcitabine—breast cancer	0.000126	0.000397	CcSEcCtD
Sodium lauryl sulfate—Nausea—Thiotepa—breast cancer	0.000125	0.000396	CcSEcCtD
Sodium lauryl sulfate—Infection—Docetaxel—breast cancer	0.000125	0.000395	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Irinotecan—breast cancer	0.000125	0.000394	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Mitoxantrone—breast cancer	0.000125	0.000394	CcSEcCtD
Sodium lauryl sulfate—Shock—Docetaxel—breast cancer	0.000124	0.000391	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Fluorouracil—breast cancer	0.000123	0.00039	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Docetaxel—breast cancer	0.000123	0.000388	CcSEcCtD
Sodium lauryl sulfate—Oedema—Capecitabine—breast cancer	0.000122	0.000385	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Paclitaxel—breast cancer	0.000122	0.000384	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Gemcitabine—breast cancer	0.000121	0.000384	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Doxorubicin—breast cancer	0.000121	0.000383	CcSEcCtD
Sodium lauryl sulfate—Infection—Capecitabine—breast cancer	0.000121	0.000383	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Irinotecan—breast cancer	0.000121	0.000381	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Docetaxel—breast cancer	0.00012	0.000379	CcSEcCtD
Sodium lauryl sulfate—Shock—Capecitabine—breast cancer	0.00012	0.000379	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Fluorouracil—breast cancer	0.000119	0.000377	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Capecitabine—breast cancer	0.000119	0.000376	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Epirubicin—breast cancer	0.000119	0.000376	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Paclitaxel—breast cancer	0.000118	0.000373	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Capecitabine—breast cancer	0.000118	0.000372	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Docetaxel—breast cancer	0.000118	0.000372	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Paclitaxel—breast cancer	0.000117	0.000371	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Paclitaxel—breast cancer	0.000117	0.000371	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Capecitabine—breast cancer	0.000116	0.000367	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Mitoxantrone—breast cancer	0.000116	0.000366	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Irinotecan—breast cancer	0.000116	0.000366	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Fluorouracil—breast cancer	0.000115	0.000364	CcSEcCtD
Sodium lauryl sulfate—Rash—Irinotecan—breast cancer	0.000115	0.000363	CcSEcCtD
Sodium lauryl sulfate—Rash—Mitoxantrone—breast cancer	0.000115	0.000363	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Mitoxantrone—breast cancer	0.000115	0.000363	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Irinotecan—breast cancer	0.000115	0.000363	CcSEcCtD
Sodium lauryl sulfate—Headache—Mitoxantrone—breast cancer	0.000114	0.000361	CcSEcCtD
Sodium lauryl sulfate—Headache—Irinotecan—breast cancer	0.000114	0.000361	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Capecitabine—breast cancer	0.000114	0.00036	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Docetaxel—breast cancer	0.000113	0.000357	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Gemcitabine—breast cancer	0.000113	0.000356	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Docetaxel—breast cancer	0.000112	0.000355	CcSEcCtD
Sodium lauryl sulfate—Rash—Gemcitabine—breast cancer	0.000112	0.000353	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Gemcitabine—breast cancer	0.000112	0.000353	CcSEcCtD
Sodium lauryl sulfate—Headache—Gemcitabine—breast cancer	0.000111	0.000351	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Fluorouracil—breast cancer	0.000111	0.00035	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Doxorubicin—breast cancer	0.00011	0.000348	CcSEcCtD
Sodium lauryl sulfate—Rash—Fluorouracil—breast cancer	0.00011	0.000348	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Fluorouracil—breast cancer	0.00011	0.000347	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Capecitabine—breast cancer	0.00011	0.000346	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Docetaxel—breast cancer	0.00011	0.000346	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Paclitaxel—breast cancer	0.00011	0.000346	CcSEcCtD
Sodium lauryl sulfate—Headache—Fluorouracil—breast cancer	0.000109	0.000345	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Methotrexate—breast cancer	0.000109	0.000344	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Capecitabine—breast cancer	0.000109	0.000343	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Docetaxel—breast cancer	0.000109	0.000343	CcSEcCtD
Sodium lauryl sulfate—Nausea—Irinotecan—breast cancer	0.000108	0.000342	CcSEcCtD
Sodium lauryl sulfate—Nausea—Mitoxantrone—breast cancer	0.000108	0.000342	CcSEcCtD
Sodium lauryl sulfate—Constipation—Docetaxel—breast cancer	0.000108	0.00034	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Epirubicin—breast cancer	0.000107	0.000337	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—CFL1—breast cancer	0.000107	0.00295	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Paclitaxel—breast cancer	0.000107	0.000337	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Capecitabine—breast cancer	0.000106	0.000335	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—MTHFR—breast cancer	0.000106	0.00292	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Gemcitabine—breast cancer	0.000105	0.000333	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Capecitabine—breast cancer	0.000105	0.000332	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Paclitaxel—breast cancer	0.000105	0.000332	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Methotrexate—breast cancer	0.000105	0.000331	CcSEcCtD
Sodium lauryl sulfate—Constipation—Capecitabine—breast cancer	0.000104	0.000329	CcSEcCtD
Sodium lauryl sulfate—Nausea—Fluorouracil—breast cancer	0.000104	0.000327	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Docetaxel—breast cancer	0.000103	0.000325	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Epirubicin—breast cancer	0.000103	0.000324	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Epirubicin—breast cancer	0.000102	0.000322	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Paclitaxel—breast cancer	0.000102	0.000321	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—FN1—breast cancer	0.0001	0.00276	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—ALDOA—breast cancer	9.99e-05	0.00276	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—VEGFC—breast cancer	9.99e-05	0.00276	CbGpPWpGaD
Sodium lauryl sulfate—Gastrointestinal pain—Capecitabine—breast cancer	9.97e-05	0.000315	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—RAD51B—breast cancer	9.96e-05	0.00275	CbGpPWpGaD
Sodium lauryl sulfate—Body temperature increased—Docetaxel—breast cancer	9.96e-05	0.000314	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Docetaxel—breast cancer	9.96e-05	0.000314	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Doxorubicin—breast cancer	9.89e-05	0.000312	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Paclitaxel—breast cancer	9.83e-05	0.00031	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Epirubicin—breast cancer	9.81e-05	0.00031	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—SERPINE1—breast cancer	9.71e-05	0.00268	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—IL1B—breast cancer	9.69e-05	0.00268	CbGpPWpGaD
Sodium lauryl sulfate—Urticaria—Capecitabine—breast cancer	9.69e-05	0.000306	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Capecitabine—breast cancer	9.64e-05	0.000304	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Capecitabine—breast cancer	9.64e-05	0.000304	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Methotrexate—breast cancer	9.64e-05	0.000304	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—FN1—breast cancer	9.53e-05	0.00263	CbGpPWpGaD
Sodium lauryl sulfate—Flatulence—Doxorubicin—breast cancer	9.49e-05	0.0003	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Methotrexate—breast cancer	9.47e-05	0.000299	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—EGF—breast cancer	9.46e-05	0.00261	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Paclitaxel—breast cancer	9.45e-05	0.000298	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Doxorubicin—breast cancer	9.43e-05	0.000298	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC39A7—breast cancer	9.43e-05	0.0026	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—COX11—breast cancer	9.43e-05	0.0026	CbGpPWpGaD
Sodium lauryl sulfate—Rash—Paclitaxel—breast cancer	9.37e-05	0.000296	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Paclitaxel—breast cancer	9.36e-05	0.000296	CcSEcCtD
Sodium lauryl sulfate—Syncope—Epirubicin—breast cancer	9.34e-05	0.000295	CcSEcCtD
Sodium lauryl sulfate—Headache—Paclitaxel—breast cancer	9.31e-05	0.000294	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Docetaxel—breast cancer	9.28e-05	0.000293	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Epirubicin—breast cancer	9.2e-05	0.000291	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Epirubicin—breast cancer	9.15e-05	0.000289	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Methotrexate—breast cancer	9.08e-05	0.000287	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Doxorubicin—breast cancer	9.08e-05	0.000287	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Docetaxel—breast cancer	9.04e-05	0.000285	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Epirubicin—breast cancer	9.02e-05	0.000285	CcSEcCtD
Sodium lauryl sulfate—Infection—Methotrexate—breast cancer	9.02e-05	0.000285	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—EGF—breast cancer	9.01e-05	0.00249	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Capecitabine—breast cancer	8.99e-05	0.000284	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Docetaxel—breast cancer	8.91e-05	0.000281	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Epirubicin—breast cancer	8.86e-05	0.00028	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—IFNG—breast cancer	8.84e-05	0.00244	CbGpPWpGaD
Sodium lauryl sulfate—Anxiety—Epirubicin—breast cancer	8.83e-05	0.000279	CcSEcCtD
Sodium lauryl sulfate—Nausea—Paclitaxel—breast cancer	8.83e-05	0.000279	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Methotrexate—breast cancer	8.78e-05	0.000277	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—IGF1—breast cancer	8.76e-05	0.00242	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Capecitabine—breast cancer	8.75e-05	0.000276	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	8.73e-05	0.00241	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—RELA—breast cancer	8.72e-05	0.00241	CbGpPWpGaD
Sodium lauryl sulfate—Anorexia—Methotrexate—breast cancer	8.65e-05	0.000273	CcSEcCtD
Sodium lauryl sulfate—Syncope—Doxorubicin—breast cancer	8.64e-05	0.000273	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Capecitabine—breast cancer	8.63e-05	0.000273	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC22A18—breast cancer	8.62e-05	0.00238	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Docetaxel—breast cancer	8.62e-05	0.000272	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Doxorubicin—breast cancer	8.51e-05	0.000269	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Epirubicin—breast cancer	8.5e-05	0.000268	CcSEcCtD
Sodium lauryl sulfate—Oedema—Epirubicin—breast cancer	8.5e-05	0.000268	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Methotrexate—breast cancer	8.48e-05	0.000268	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—RAD51C—breast cancer	8.47e-05	0.00234	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SERPINB2—breast cancer	8.47e-05	0.00234	CbGpPWpGaD
Sodium lauryl sulfate—Loss of consciousness—Doxorubicin—breast cancer	8.47e-05	0.000267	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC2A2—breast cancer	8.46e-05	0.00234	CbGpPWpGaD
Sodium lauryl sulfate—Infection—Epirubicin—breast cancer	8.44e-05	0.000267	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—TGFB2—breast cancer	8.41e-05	0.00232	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—THBS1—breast cancer	8.37e-05	0.00231	CbGpPWpGaD
Sodium lauryl sulfate—Shock—Epirubicin—breast cancer	8.36e-05	0.000264	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—breast cancer	8.35e-05	0.00231	CbGpPWpGaD
Sodium lauryl sulfate—Convulsion—Doxorubicin—breast cancer	8.35e-05	0.000264	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Capecitabine—breast cancer	8.35e-05	0.000264	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Docetaxel—breast cancer	8.33e-05	0.000263	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—SERPINE1—breast cancer	8.32e-05	0.0023	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC2A5—breast cancer	8.3e-05	0.00229	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLCO1B1—breast cancer	8.3e-05	0.00229	CbGpPWpGaD
Sodium lauryl sulfate—Tachycardia—Epirubicin—breast cancer	8.29e-05	0.000262	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—PDE2A—breast cancer	8.25e-05	0.00228	CbGpPWpGaD
Sodium lauryl sulfate—Hyperhidrosis—Epirubicin—breast cancer	8.21e-05	0.000259	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Doxorubicin—breast cancer	8.2e-05	0.000259	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Doxorubicin—breast cancer	8.17e-05	0.000258	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Methotrexate—breast cancer	8.15e-05	0.000257	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Epirubicin—breast cancer	8.1e-05	0.000256	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Methotrexate—breast cancer	8.09e-05	0.000256	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Capecitabine—breast cancer	8.07e-05	0.000255	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Docetaxel—breast cancer	8.01e-05	0.000253	CcSEcCtD
Sodium lauryl sulfate—Rash—Docetaxel—breast cancer	7.94e-05	0.000251	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Epirubicin—breast cancer	7.94e-05	0.000251	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Docetaxel—breast cancer	7.94e-05	0.000251	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—breast cancer	7.93e-05	0.00219	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	7.92e-05	0.00219	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	7.92e-05	0.00219	CbGpPWpGaD
Sodium lauryl sulfate—Decreased appetite—Methotrexate—breast cancer	7.89e-05	0.000249	CcSEcCtD
Sodium lauryl sulfate—Headache—Docetaxel—breast cancer	7.89e-05	0.000249	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL1B—breast cancer	7.88e-05	0.00218	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—KDM1A—breast cancer	7.87e-05	0.00217	CbGpPWpGaD
Sodium lauryl sulfate—Oedema—Doxorubicin—breast cancer	7.86e-05	0.000248	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Doxorubicin—breast cancer	7.86e-05	0.000248	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL2—breast cancer	7.85e-05	0.00217	CbGpPWpGaD
Sodium lauryl sulfate—Fatigue—Methotrexate—breast cancer	7.83e-05	0.000247	CcSEcCtD
Sodium lauryl sulfate—Infection—Doxorubicin—breast cancer	7.81e-05	0.000247	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Capecitabine—breast cancer	7.75e-05	0.000245	CcSEcCtD
Sodium lauryl sulfate—Shock—Doxorubicin—breast cancer	7.74e-05	0.000244	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—SERPINE1—breast cancer	7.71e-05	0.00213	CbGpPWpGaD
Sodium lauryl sulfate—Rash—Capecitabine—breast cancer	7.69e-05	0.000243	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Capecitabine—breast cancer	7.68e-05	0.000243	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Doxorubicin—breast cancer	7.67e-05	0.000242	CcSEcCtD
Sodium lauryl sulfate—Headache—Capecitabine—breast cancer	7.64e-05	0.000241	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Epirubicin—breast cancer	7.63e-05	0.000241	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Doxorubicin—breast cancer	7.6e-05	0.00024	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Epirubicin—breast cancer	7.58e-05	0.000239	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—STIM1—breast cancer	7.55e-05	0.00208	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HADHB—breast cancer	7.51e-05	0.00208	CbGpPWpGaD
Sodium lauryl sulfate—Anorexia—Doxorubicin—breast cancer	7.49e-05	0.000237	CcSEcCtD
Sodium lauryl sulfate—Nausea—Docetaxel—breast cancer	7.48e-05	0.000236	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Methotrexate—breast cancer	7.42e-05	0.000234	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Epirubicin—breast cancer	7.39e-05	0.000233	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Doxorubicin—breast cancer	7.35e-05	0.000232	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Epirubicin—breast cancer	7.33e-05	0.000231	CcSEcCtD
Sodium lauryl sulfate—Constipation—Epirubicin—breast cancer	7.27e-05	0.000229	CcSEcCtD
Sodium lauryl sulfate—Nausea—Capecitabine—breast cancer	7.24e-05	0.000229	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Methotrexate—breast cancer	7.21e-05	0.000228	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Methotrexate—breast cancer	7.18e-05	0.000227	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Methotrexate—breast cancer	7.18e-05	0.000227	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC39A6—breast cancer	7.14e-05	0.00197	CbGpPWpGaD
Sodium lauryl sulfate—Paraesthesia—Doxorubicin—breast cancer	7.06e-05	0.000223	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—TNF—breast cancer	7.03e-05	0.00194	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—IFNG—breast cancer	7.02e-05	0.00194	CbGpPWpGaD
Sodium lauryl sulfate—Dyspnoea—Doxorubicin—breast cancer	7.01e-05	0.000221	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Epirubicin—breast cancer	6.95e-05	0.000219	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—RELA—breast cancer	6.93e-05	0.00191	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—FHL2—breast cancer	6.87e-05	0.0019	CbGpPWpGaD
Sodium lauryl sulfate—Decreased appetite—Doxorubicin—breast cancer	6.83e-05	0.000216	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC5A5—breast cancer	6.78e-05	0.00187	CbGpPWpGaD
Sodium lauryl sulfate—Fatigue—Doxorubicin—breast cancer	6.78e-05	0.000214	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Epirubicin—breast cancer	6.75e-05	0.000213	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—PTGS2—breast cancer	6.73e-05	0.00186	CbGpPWpGaD
Sodium lauryl sulfate—Constipation—Doxorubicin—breast cancer	6.72e-05	0.000212	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Epirubicin—breast cancer	6.72e-05	0.000212	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Epirubicin—breast cancer	6.72e-05	0.000212	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Methotrexate—breast cancer	6.69e-05	0.000211	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PLG—breast cancer	6.65e-05	0.00184	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—F3—breast cancer	6.6e-05	0.00182	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC2A1—breast cancer	6.55e-05	0.00181	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ATP7B—breast cancer	6.53e-05	0.0018	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Methotrexate—breast cancer	6.51e-05	0.000206	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Doxorubicin—breast cancer	6.43e-05	0.000203	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Methotrexate—breast cancer	6.42e-05	0.000203	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	6.39e-05	0.00176	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PDGFA—breast cancer	6.31e-05	0.00174	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—IL1B—breast cancer	6.26e-05	0.00173	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Epirubicin—breast cancer	6.26e-05	0.000198	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Doxorubicin—breast cancer	6.25e-05	0.000197	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Doxorubicin—breast cancer	6.22e-05	0.000196	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Doxorubicin—breast cancer	6.22e-05	0.000196	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Methotrexate—breast cancer	6.21e-05	0.000196	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	6.19e-05	0.00171	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—ITPR1—breast cancer	6.12e-05	0.00169	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Epirubicin—breast cancer	6.1e-05	0.000193	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCC1—breast cancer	6.07e-05	0.00168	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Epirubicin—breast cancer	6.01e-05	0.00019	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Methotrexate—breast cancer	6e-05	0.00019	CcSEcCtD
Sodium lauryl sulfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	5.89e-05	0.00163	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Epirubicin—breast cancer	5.81e-05	0.000184	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Doxorubicin—breast cancer	5.79e-05	0.000183	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Methotrexate—breast cancer	5.77e-05	0.000182	CcSEcCtD
Sodium lauryl sulfate—Rash—Methotrexate—breast cancer	5.72e-05	0.000181	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—VEGFA—breast cancer	5.72e-05	0.00158	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—TNF—breast cancer	5.72e-05	0.00158	CbGpPWpGaD
Sodium lauryl sulfate—Dermatitis—Methotrexate—breast cancer	5.72e-05	0.000181	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—HGF—breast cancer	5.72e-05	0.00158	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PLA2G4A—breast cancer	5.72e-05	0.00158	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—GPX2—breast cancer	5.69e-05	0.00157	CbGpPWpGaD
Sodium lauryl sulfate—Headache—Methotrexate—breast cancer	5.69e-05	0.00018	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—IL6—breast cancer	5.67e-05	0.00157	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—CSF2—breast cancer	5.65e-05	0.00156	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Doxorubicin—breast cancer	5.64e-05	0.000178	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—GPX4—breast cancer	5.62e-05	0.00155	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Epirubicin—breast cancer	5.62e-05	0.000177	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Doxorubicin—breast cancer	5.56e-05	0.000176	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—CFL1—breast cancer	5.51e-05	0.00152	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—IDH1—breast cancer	5.49e-05	0.00152	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—GRB7—breast cancer	5.46e-05	0.00151	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—breast cancer	5.45e-05	0.00151	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Epirubicin—breast cancer	5.4e-05	0.000171	CcSEcCtD
Sodium lauryl sulfate—Nausea—Methotrexate—breast cancer	5.39e-05	0.00017	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Doxorubicin—breast cancer	5.38e-05	0.00017	CcSEcCtD
Sodium lauryl sulfate—Rash—Epirubicin—breast cancer	5.36e-05	0.000169	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Epirubicin—breast cancer	5.35e-05	0.000169	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism—SYNJ2—breast cancer	5.33e-05	0.00147	CbGpPWpGaD
Sodium lauryl sulfate—Headache—Epirubicin—breast cancer	5.32e-05	0.000168	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—TGFB1—breast cancer	5.25e-05	0.00145	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Doxorubicin—breast cancer	5.2e-05	0.000164	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—TUBB3—breast cancer	5.16e-05	0.00143	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—VEGFC—breast cancer	5.15e-05	0.00142	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ALDOA—breast cancer	5.15e-05	0.00142	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Epirubicin—breast cancer	5.05e-05	0.000159	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—TP53—breast cancer	5.04e-05	0.00139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—breast cancer	5e-05	0.00138	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Doxorubicin—breast cancer	5e-05	0.000158	CcSEcCtD
Sodium lauryl sulfate—Rash—Doxorubicin—breast cancer	4.96e-05	0.000157	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism—NDUFS3—breast cancer	4.95e-05	0.00137	CbGpPWpGaD
Sodium lauryl sulfate—Dermatitis—Doxorubicin—breast cancer	4.95e-05	0.000156	CcSEcCtD
Sodium lauryl sulfate—Headache—Doxorubicin—breast cancer	4.93e-05	0.000156	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—MED12—breast cancer	4.76e-05	0.00132	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Doxorubicin—breast cancer	4.67e-05	0.000147	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism—CHST9—breast cancer	4.66e-05	0.00129	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL6—breast cancer	4.62e-05	0.00128	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	4.55e-05	0.00126	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—TNF—breast cancer	4.54e-05	0.00126	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—FN1—breast cancer	4.44e-05	0.00123	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	4.43e-05	0.00122	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—COX11—breast cancer	4.41e-05	0.00122	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	4.34e-05	0.0012	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TGFB2—breast cancer	4.33e-05	0.0012	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—THBS1—breast cancer	4.31e-05	0.00119	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC2A2—breast cancer	4.3e-05	0.00119	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—GATA3—breast cancer	4.25e-05	0.00117	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CG—breast cancer	4.24e-05	0.00117	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ACHE—breast cancer	4.21e-05	0.00116	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCG2—breast cancer	4.21e-05	0.00116	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—EGF—breast cancer	4.2e-05	0.00116	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SHMT1—breast cancer	4.04e-05	0.00112	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CDA—breast cancer	4.04e-05	0.00112	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.99e-05	0.0011	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.95e-05	0.00109	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLCO1B1—breast cancer	3.89e-05	0.00107	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC2A5—breast cancer	3.89e-05	0.00107	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—IGF1—breast cancer	3.89e-05	0.00107	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—AKT2—breast cancer	3.88e-05	0.00107	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IFNB1—breast cancer	3.82e-05	0.00105	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.8e-05	0.00105	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—APRT—breast cancer	3.75e-05	0.00104	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—TFRC—breast cancer	3.75e-05	0.00104	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CD—breast cancer	3.73e-05	0.00103	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SERPINE1—breast cancer	3.69e-05	0.00102	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.68e-05	0.00102	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.67e-05	0.00101	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—IL6—breast cancer	3.67e-05	0.00101	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—NCOA2—breast cancer	3.61e-05	0.000998	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ESRRA—breast cancer	3.53e-05	0.000975	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ANGPTL4—breast cancer	3.53e-05	0.000975	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PLAUR—breast cancer	3.51e-05	0.000969	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.45e-05	0.000952	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PLG—breast cancer	3.43e-05	0.000947	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	3.36e-05	0.000927	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GPI—breast cancer	3.35e-05	0.000924	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HADHB—breast cancer	3.35e-05	0.000924	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—RAF1—breast cancer	3.33e-05	0.00092	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.33e-05	0.000919	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PDGFA—breast cancer	3.25e-05	0.000899	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CB—breast cancer	3.25e-05	0.000899	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	3.2e-05	0.000884	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ALDH1A1—breast cancer	3.19e-05	0.000882	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ALDH7A1—breast cancer	3.19e-05	0.000882	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ITPR1—breast cancer	3.16e-05	0.000872	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	3.15e-05	0.000872	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ABL1—breast cancer	3.13e-05	0.000866	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—FHL2—breast cancer	3.06e-05	0.000845	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NME1—breast cancer	3.06e-05	0.000845	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ADSL—breast cancer	3.06e-05	0.000845	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PHGDH—breast cancer	3.06e-05	0.000845	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—UMPS—breast cancer	3.06e-05	0.000845	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—NCOA1—breast cancer	3.04e-05	0.000841	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—LDHB—breast cancer	3e-05	0.000829	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—BRIP1—breast cancer	3e-05	0.000829	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HPSE—breast cancer	3e-05	0.000829	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—IL2—breast cancer	2.99e-05	0.000825	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—PLG—breast cancer	2.97e-05	0.000819	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—HGF—breast cancer	2.95e-05	0.000814	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PLA2G4A—breast cancer	2.95e-05	0.000814	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CSF2—breast cancer	2.91e-05	0.000805	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HMMR—breast cancer	2.84e-05	0.000786	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTA3—breast cancer	2.84e-05	0.000786	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ABCC1—breast cancer	2.84e-05	0.000786	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PPARGC1B—breast cancer	2.76e-05	0.000761	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—HMOX1—breast cancer	2.74e-05	0.000756	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.68e-05	0.000741	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.68e-05	0.000741	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCB1—breast cancer	2.63e-05	0.000726	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SRC—breast cancer	2.61e-05	0.00072	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTA4—breast cancer	2.6e-05	0.000719	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CA9—breast cancer	2.6e-05	0.000719	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.57e-05	0.00071	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.54e-05	0.000703	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—VEGFA—breast cancer	2.54e-05	0.000701	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTA2—breast cancer	2.54e-05	0.0007	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GPX2—breast cancer	2.54e-05	0.0007	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—MMP1—breast cancer	2.51e-05	0.000692	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GPX4—breast cancer	2.5e-05	0.000692	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SULT1A1—breast cancer	2.5e-05	0.000692	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PLAU—breast cancer	2.46e-05	0.000679	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CDK2—breast cancer	2.46e-05	0.000679	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTA1—breast cancer	2.45e-05	0.000676	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—IDH1—breast cancer	2.45e-05	0.000676	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NAT2—breast cancer	2.42e-05	0.000668	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CAV1—breast cancer	2.4e-05	0.000664	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	2.4e-05	0.000663	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	2.33e-05	0.000644	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—FN1—breast cancer	2.29e-05	0.000632	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—NOS2—breast cancer	2.26e-05	0.000624	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CG—breast cancer	2.19e-05	0.000604	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.19e-05	0.000604	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—EGF—breast cancer	2.16e-05	0.000597	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MED12—breast cancer	2.12e-05	0.000586	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—DPYD—breast cancer	2.12e-05	0.000586	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ALDOA—breast cancer	2.09e-05	0.000577	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOA3—breast cancer	2.03e-05	0.00056	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC2A2—breast cancer	2.01e-05	0.000556	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IGF1—breast cancer	2e-05	0.000553	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—AKT2—breast cancer	2e-05	0.000553	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.99e-05	0.00055	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	1.98e-05	0.000548	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ABCG2—breast cancer	1.97e-05	0.000545	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CPT1A—breast cancer	1.97e-05	0.000545	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MTR—breast cancer	1.97e-05	0.000545	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HPGDS—breast cancer	1.93e-05	0.000534	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CD—breast cancer	1.92e-05	0.000531	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HBA1—breast cancer	1.92e-05	0.000531	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SERPINE1—breast cancer	1.9e-05	0.000526	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ACHE—breast cancer	1.88e-05	0.000518	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTT1—breast cancer	1.88e-05	0.000518	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—NOS3—breast cancer	1.82e-05	0.000502	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP17A1—breast cancer	1.78e-05	0.00049	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PTGS1—breast cancer	1.76e-05	0.000486	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ENO1—breast cancer	1.76e-05	0.000486	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.75e-05	0.000484	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP2D6—breast cancer	1.72e-05	0.000476	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—RAF1—breast cancer	1.72e-05	0.000474	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOA2—breast cancer	1.69e-05	0.000467	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CB—breast cancer	1.68e-05	0.000463	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—FASN—breast cancer	1.64e-05	0.000453	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—BCHE—breast cancer	1.63e-05	0.000451	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	1.62e-05	0.000447	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC5A5—breast cancer	1.61e-05	0.000446	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NQO1—breast cancer	1.56e-05	0.000431	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC2A1—breast cancer	1.56e-05	0.000431	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IL2—breast cancer	1.54e-05	0.000425	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.53e-05	0.000422	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP3A4—breast cancer	1.52e-05	0.00042	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.51e-05	0.000418	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP1B1—breast cancer	1.49e-05	0.000413	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	1.49e-05	0.000411	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HSP90AA1—breast cancer	1.47e-05	0.000405	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOA1—breast cancer	1.43e-05	0.000394	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—STK11—breast cancer	1.41e-05	0.000388	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP19A1—breast cancer	1.41e-05	0.000388	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SRC—breast cancer	1.34e-05	0.000371	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.32e-05	0.000364	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—VEGFA—breast cancer	1.31e-05	0.000361	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—COMT—breast cancer	1.31e-05	0.000361	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTP1—breast cancer	1.3e-05	0.000359	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HMOX1—breast cancer	1.28e-05	0.000354	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ITPR1—breast cancer	1.28e-05	0.000353	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—MAPK3—breast cancer	1.24e-05	0.000342	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ABCB1—breast cancer	1.23e-05	0.00034	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—TYMS—breast cancer	1.21e-05	0.000334	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TGFB1—breast cancer	1.2e-05	0.000332	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTM1—breast cancer	1.19e-05	0.00033	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOR1—breast cancer	1.19e-05	0.00033	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PLA2G4A—breast cancer	1.19e-05	0.00033	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GPX1—breast cancer	1.14e-05	0.000316	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP1A1—breast cancer	1.13e-05	0.000313	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ERCC2—breast cancer	1.12e-05	0.00031	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—KRAS—breast cancer	1.11e-05	0.000307	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MTHFR—breast cancer	1.06e-05	0.000292	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CA—breast cancer	1.02e-05	0.000282	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TP53—breast cancer	9.89e-06	0.000273	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CAV1—breast cancer	9.74e-06	0.000269	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—HRAS—breast cancer	9.46e-06	0.000261	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.3e-06	0.000257	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CG—breast cancer	8.87e-06	0.000245	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—AKT1—breast cancer	8.35e-06	0.000231	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CD—breast cancer	7.8e-06	0.000215	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NOS3—breast cancer	7.36e-06	0.000203	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CB—breast cancer	6.8e-06	0.000188	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PTGS2—breast cancer	6.74e-06	0.000186	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PTEN—breast cancer	5.87e-06	0.000162	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CA—breast cancer	4.14e-06	0.000114	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AKT1—breast cancer	3.39e-06	9.35e-05	CbGpPWpGaD
